FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to compounds of formula
and to pharmaceutically acceptable salts, stereoisomers and to pharmaceutical compositions containing them which are effective for canal activating protease modulation, such as prostasin or trypsin.
EFFECT: preparing new compounds and applying such compounds for prostasin or trypsin inhibition.
17 cl, 1 tbl, 258 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS AND COMPOSITIONS AS CANAL ACTIVATING PROTEASE INHIBITORS | 2007 |
|
RU2419625C2 |
| PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR CCR5 | 2005 |
|
RU2368608C2 |
| COMPOUNDS AND COMPOSITIONS OF 5-(4-(HALOGENALKOXY)PHENYL)PYRIMIDIN-2-AMINE AS KINASE INHIBITORS | 2008 |
|
RU2455288C2 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
| NEW CONDENSED HETEROCYCLIC COMPOUNDS AND THEIR USE | 2004 |
|
RU2374251C2 |
| PYRROLOTRIAZINE ANILINE DERIVATIVES EFFECTIVE AS KINASE INHIBITORS | 2003 |
|
RU2375363C2 |
| OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2744267C2 |
| COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR THEIR USE | 2013 |
|
RU2666146C2 |
| CASPASE INHIBITOR PRODRUGS | 2006 |
|
RU2427582C2 |
| SUBSTITUTED QUINAZINE DERIVATIVES AS FGFR-KINASE INHIBITORS FOR TREATMENT OF CANCER | 2011 |
|
RU2602233C2 |
